220 related articles for article (PubMed ID: 24379443)
21. The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes.
Zhang Y; Lei T; Huang JF; Wang SB; Zhou LL; Yang ZQ; Chen XD
Mol Cell Endocrinol; 2011 Aug; 342(1-2):41-7. PubMed ID: 21664250
[TBL] [Abstract][Full Text] [Related]
22. Repression of E1AF transcriptional activity by sumoylation and PIASy.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem Biophys Res Commun; 2007 Aug; 360(1):226-32. PubMed ID: 17585876
[TBL] [Abstract][Full Text] [Related]
23. Hepatic mTOR-AKT2-Insig2 signaling pathway contributes to the improvement of hepatic steatosis after Roux-en-Y Gastric Bypass in mice.
Pan Q; Qin T; Gao Y; Li S; Li D; Peng M; Zhai H; Xu G
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):525-534. PubMed ID: 30562559
[TBL] [Abstract][Full Text] [Related]
24. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
Mabb AM; Wuerzberger-Davis SM; Miyamoto S
Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
[TBL] [Abstract][Full Text] [Related]
25. SUMOylation and Ubiquitylation Circuitry Controls Pregnane X Receptor Biology in Hepatocytes.
Cui W; Sun M; Galeva N; Williams TD; Azuma Y; Staudinger JL
Drug Metab Dispos; 2015 Sep; 43(9):1316-25. PubMed ID: 26063058
[TBL] [Abstract][Full Text] [Related]
26. Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.
Imoto S; Ohbayashi N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
Biochem Biophys Res Commun; 2008 May; 370(2):359-65. PubMed ID: 18384750
[TBL] [Abstract][Full Text] [Related]
27. KLF15 Enables Rapid Switching between Lipogenesis and Gluconeogenesis during Fasting.
Takeuchi Y; Yahagi N; Aita Y; Murayama Y; Sawada Y; Piao X; Toya N; Oya Y; Shikama A; Takarada A; Masuda Y; Nishi M; Kubota M; Izumida Y; Yamamoto T; Sekiya M; Matsuzaka T; Nakagawa Y; Urayama O; Kawakami Y; Iizuka Y; Gotoda T; Itaka K; Kataoka K; Nagai R; Kadowaki T; Yamada N; Lu Y; Jain MK; Shimano H
Cell Rep; 2016 Aug; 16(9):2373-86. PubMed ID: 27545894
[TBL] [Abstract][Full Text] [Related]
28. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
29. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
Dütting E; Schröder-Kress N; Sticht H; Enz R
Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
[TBL] [Abstract][Full Text] [Related]
30. Protein inhibitor of activated STAT Y (PIASy) and a splice variant lacking exon 6 enhance sumoylation but are not essential for embryogenesis and adult life.
Wong KA; Kim R; Christofk H; Gao J; Lawson G; Wu H
Mol Cell Biol; 2004 Jun; 24(12):5577-86. PubMed ID: 15169916
[TBL] [Abstract][Full Text] [Related]
31. Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes.
Li N; Li M; Hong W; Shao J; Xu H; Shimano H; Lu J; Xu Y
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2881-2889. PubMed ID: 29857051
[TBL] [Abstract][Full Text] [Related]
32. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
[TBL] [Abstract][Full Text] [Related]
33. SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors.
Cox B; Briscoe J; Ulloa F
PLoS One; 2010 Aug; 5(8):e11996. PubMed ID: 20711444
[TBL] [Abstract][Full Text] [Related]
34. SUMO E3 Ligase PIASy Mediates High Glucose-Induced Activation of NF-
Huang W; Liang Y; Dong J; Zhou L; Gao C; Jiang C; Chen M; Long Y; Xu Y
Mediators Inflamm; 2017; 2017():1685194. PubMed ID: 29038616
[TBL] [Abstract][Full Text] [Related]
35. FoxO3 regulates hepatic triglyceride metabolism via modulation of the expression of sterol regulatory-element binding protein 1c.
Wang L; Zhu X; Sun X; Yang X; Chang X; Xia M; Lu Y; Xia P; Yan H; Bian H; Gao X
Lipids Health Dis; 2019 Nov; 18(1):197. PubMed ID: 31729980
[TBL] [Abstract][Full Text] [Related]
36. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways.
Yecies JL; Zhang HH; Menon S; Liu S; Yecies D; Lipovsky AI; Gorgun C; Kwiatkowski DJ; Hotamisligil GS; Lee CH; Manning BD
Cell Metab; 2011 Jul; 14(1):21-32. PubMed ID: 21723501
[TBL] [Abstract][Full Text] [Related]
37. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
Oh Y; Chung KC
J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
[TBL] [Abstract][Full Text] [Related]
38. PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1.
Nishida T; Terashima M; Fukami K; Yamada Y
Biochem J; 2007 Aug; 405(3):481-8. PubMed ID: 17456046
[TBL] [Abstract][Full Text] [Related]
39. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
40. Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization.
Fuhs SR; Insel PA
J Biol Chem; 2011 Apr; 286(17):14830-41. PubMed ID: 21362625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
